首页> 外文期刊>Medicine. >Glucose metabolism of visceral adipose tissue measured by 18F-FDG PET/CT is related to the presence of colonic adenoma
【24h】

Glucose metabolism of visceral adipose tissue measured by 18F-FDG PET/CT is related to the presence of colonic adenoma

机译:通过18F-FDG PET / CT测量的内脏脂肪组织的葡萄糖代谢与结肠腺瘤的存在有关

获取原文
           

摘要

This study investigated the relationships between the area and metabolic activity of adipose tissue and the presence of colorectal adenoma (CRA). Our institutional review board approved the study and waived informed consent. A total of 212 subjects who underwent fluorine 18 fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) and colonoscopy for routine health check-ups were enrolled. The volumetric parameters of areas of visceral (VATav), subcutaneous (SATav), and total adipose tissue (TATav) and calculated visceral-to-subcutaneous adipose tissue ratio (VSR) and visceral-to-total adipose tissue ratio (VAR) were considered. Metabolic parameters of standardized uptake value (SUV) of visceral (vcSUVmax, vcSUVmean), subcutaneous (scSUVmax, scSUVmean), and calculated visceral-to-subcutaneous adipose tissue ratio (VSRmax, VSRmean) were considered. Anthropometric data of height, weight, body mass index (BMI), waist circumference (WC), body fat mass (BFM), skeletal muscle mass (SMM), and diverse laboratory data were also considered as variables. Sixty-six subjects were placed in the CRA group and 146 subjects in the non-CRA group. The presence of CRA was significantly correlated with older age ( P = .001), male sex ( P = .041), higher BMI ( P = .004), higher WC ( P = .001), higher BFM ( P = .024), higher VATav ( P av ( P = .004), higher VSR ( P vcSUVmax ( P = .002), lower vcSUVmean ( P mean ( P = .002). On multiple regression analysis, vcSUVmax and vcSUVmean were independently associated with the presence of CRA ( P = .009 and P = .045). Lower glucose metabolism of visceral adipose tissue was related to the presence of CRA. Our findings identify the value of visceral metabolic dysfunction as a potential surrogate marker of elevated risk for CRA.
机译:本研究研究了脂肪组织的面积和代谢活性与结肠直肠腺瘤(CRA)的存在关系。我们的机构审查委员会批准了该研究并放弃了知情同意。共有212名接受氟18氟氧氧(FDG)正电子发射断层扫描(PET)/计算机断层扫描(CT)和结肠镜检查的常规健康检查的212项受试者。内脏区域的体积参数(VAT av ),皮下(sat av ),以及总脂肪组织(tat av < /亚>)和计算的内脏对皮下脂肪组织比(VSR)和内脏至总脂肪组织比(VAR)被认为是。内脏标准化摄取值(SUV)的代谢参数( vc suv 最大 vc suv 均值),皮下( sc suv max SC suv 均值),并计算内心对皮下脂肪组织比率(vsr max ,vsr 平均值。高度,体重,体重指数(BMI),腰围(WC),体脂肪量(BFM),骨骼肌质量(SMM)以及多样化的实验室数据的人体测量数据也被认为是变量。将六十六个受试者置于CRA组和146名受试者中的非CRA组。 CRA的存在与年龄(p = 0.001)显着相关(p = .041),较高的BMI(P = .004),更高的WC(P = .001),更高的BFM(P =。 024),较高的VAT av (p av (p = .004),更高的vsr(p VC suv max (p = .002),下vc均值(p意味着< / sub>(p = .002)。在多元回归分析中, vc suv max vc suv <子XMLNS:MRWS =“http://webservices.ovid.com/mrws/1.0”>均值与CRA​​的存在独立相关(p = .009和p = .045)。降低葡萄糖代谢内脏脂肪组织与存在有关CRA。我们的研究结果确定了内粘性代谢功能障碍的价值,作为CRA风险升高的潜在替代标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号